オステオポンチン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "オステオポンチン" in Japanese language version.

refsWebsite

Global rank Japanese rank

182nih.gov

4^th place

24^th place

102doi.org

2^nd place

6^th place

8harvard.edu

18^th place

107^th place

2ensembl.org

1,626^th place

2,625^th place

2wikipedia.org

low place

1hpcr.jp

low place

1rutgers.edu

1,999^th place

4,784^th place

1zenodo.org

621^st place

4,635^th place

1worldcat.org

5^th place

19^th place

1bbc.co.uk

8^th place

73^rd place

bbc.co.uk

news.bbc.co.uk

Mori R, Shaw TJ, Martin P (January 2008). “Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring”. The Journal of Experimental Medicine 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
- “Gel 'to speed up wound healing'”. BBC News. (2008年1月22日)

doi.org

Kalmar L, Homola D, Varga G, Tompa P (September 2012). “Structural disorder in proteins brings order to crystal growth in biomineralization”. Bone 51 (3): 528–534. doi:10.1016/j.bone.2012.05.009. PMID 22634174.
Wang KX, Denhardt DT (2008). “Osteopontin: role in immune regulation and stress responses”. Cytokine & Growth Factor Reviews 19 (5–6): 333–345. doi:10.1016/j.cytogfr.2008.08.001. PMID 18952487.
Rangaswami H, Bulbule A, Kundu GC (February 2006). “Osteopontin: role in cell signaling and cancer progression”. Trends in Cell Biology 16 (2): 79–87. doi:10.1016/j.tcb.2005.12.005. PMID 16406521.
Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (August 1990). “cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)”. Genomics 7 (4): 491–502. doi:10.1016/0888-7543(90)90191-V. PMID 1974876. https://zenodo.org/record/1258571.
Kiefer MC, Bauer DM, Barr PJ (April 1989). “The cDNA and derived amino acid sequence for human osteopontin”. Nucleic Acids Research 17 (8): 3306. doi:10.1093/nar/17.8.3306. PMC 317745. PMID 2726470.
Crosby AH, Edwards SJ, Murray JC, Dixon MJ (May 1995). “Genomic organization of the human osteopontin gene: exclusion of the locus from a causative role in the pathogenesis of dentinogenesis imperfecta type II”. Genomics 27 (1): 155–160. doi:10.1006/geno.1995.1018. PMID 7665163.
Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, Carmona AK, McKee MD (March 2013). “Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia”. Journal of Bone and Mineral Research 28 (3): 688–699. doi:10.1002/jbmr.1766. PMID 22991293.
Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F (August 1991). “Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis”. The Journal of Clinical Investigation 88 (2): 546–552. doi:10.1172/JCI115338. PMC 295383. PMID 1830891.
Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). “Osteopontin--a possible anchor of osteoclasts to bone”. Proceedings of the National Academy of Sciences of the United States of America 87 (12): 4473–4475. Bibcode: 1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
Banerjee A, Apte UM, Smith R, Ramaiah SK (March 2006). “Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease”. The Journal of Pathology 208 (4): 473–485. doi:10.1002/path.1917. PMID 16440289.
Sodek J, Batista Da Silva AP, Zohar R (May 2006). “Osteopontin and mucosal protection”. Journal of Dental Research 85 (5): 404–415. doi:10.1177/154405910608500503. PMID 16632752. ^{[リンク切れ]}
Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (July 2000). “Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration”. Journal of Cellular Physiology 184 (1): 118–130. doi:10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y. PMID 10825241.
Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (August 2002). “Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts”. Journal of Bone and Mineral Research 17 (8): 1486–1497. doi:10.1359/jbmr.2002.17.8.1486. PMID 12162503.
Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J (January 2004). “Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin”. Journal of Cellular Physiology 198 (1): 155–167. doi:10.1002/jcp.10394. PMID 14584055.
Junaid A, Moon MC, Harding GE, Zahradka P (February 2007). “Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1”. American Journal of Physiology. Cell Physiology 292 (2): C919–C926. doi:10.1152/ajpcell.00477.2006. PMID 17005603.
Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). “Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells”. Proceedings of the National Academy of Sciences of the United States of America 105 (20): 7235–7239. Bibcode: 2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
He B, Mirza M, Weber GF (April 2006). “An osteopontin splice variant induces anchorage independence in human breast cancer cells”. Oncogene 25 (15): 2192–2202. doi:10.1038/sj.onc.1209248. PMID 16288209.
Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, Weber GF (February 2008). “Osteopontin-c is a selective marker of breast cancer”. International Journal of Cancer 122 (4): 889–897. doi:10.1002/ijc.23204. PMID 17960616.
Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA (November 1996). “Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction”. The Journal of Clinical Investigation 98 (10): 2218–2227. doi:10.1172/JCI119031. PMC 507670. PMID 8941637.
Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K (December 1993). “Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta”. The Journal of Clinical Investigation 92 (6): 2814–2820. doi:10.1172/JCI116901. PMC 288482. PMID 8254036.
Uaesoontrachoon K, Yoo HJ, Tudor EM, Pike RN, Mackie EJ, Pagel CN (April 2008). “Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro”. The International Journal of Biochemistry & Cell Biology 40 (10): 2303–2314. doi:10.1016/j.biocel.2008.03.020. PMID 18490187.
Merry K, Dodds R, Littlewood A, Gowen M (April 1993). “Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone”. Journal of Cell Science 104 (4): 1013–1020. doi:10.1242/jcs.104.4.1013. PMID 8314886.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (January 2002). “The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation”. Cell 108 (1): 17–29. doi:10.1016/S0092-8674(01)00622-5. PMID 11792318.
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (May 1997). “Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation”. Cell 89 (5): 747–754. doi:10.1016/S0092-8674(00)80257-3. PMID 9182762.
Prince CW, Butler WT (September 1987). “1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells”. Collagen and Related Research 7 (4): 305–313. doi:10.1016/s0174-173x(87)80036-5. PMID 3478171.
Oldberg A, Jirskog-Hed B, Axelsson S, Heinegård D (December 1989). “Regulation of bone sialoprotein mRNA by steroid hormones”. The Journal of Cell Biology 109 (6 Pt 1): 3183–3186. doi:10.1083/jcb.109.6.3183. PMC 2115918. PMID 2592421.
Pereira TA, Vaz de Melo Trindade G, Trindade Santos E, Pereira FE, Souza MM (May 2021). “Praziquantel pharmacotherapy reduces systemic osteopontin levels and liver collagen content in murine schistosomiasis mansoni”. International Journal for Parasitology 51 (6): 437–440. doi:10.1016/j.ijpara.2020.11.002. PMID 33493521.
“Editorial”. International Journal for Parasitology 26 (8–9): 797–798. (1996-08-09). doi:10.1016/0020-7519(96)00065-3. ISSN 0020-7519.
Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (January 2009). “Phosphate regulates osteopontin gene transcription”. Journal of Dental Research 88 (1): 39–44. doi:10.1177/0022034508328072. PMC 3128439. PMID 19131315.
Guo H, Cai CQ, Schroeder RA, Kuo PC (January 2001). “Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages”. Journal of Immunology 166 (2): 1079–1086. doi:10.4049/jimmunol.166.2.1079. PMID 11145688.
Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR (May 2000). “Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells”. American Journal of Physiology. Renal Physiology 278 (5): F708–F716. doi:10.1152/ajprenal.2000.278.5.F708. PMID 10807582.
Noda M, Rodan GA (February 1989). “Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone”. The Journal of Cell Biology 108 (2): 713–718. doi:10.1083/jcb.108.2.713. PMC 2115413. PMID 2465299.
Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ (January 2001). “TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements”. Experimental Cell Research 262 (1): 69–74. doi:10.1006/excr.2000.5074. PMID 11120606.
Sodhi CP, Phadke SA, Batlle D, Sahai A (April 2001). “Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin”. American Journal of Physiology. Renal Physiology 280 (4): F667–F674. doi:10.1152/ajprenal.2001.280.4.F667. PMID 11249858.
Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (May 2001). “Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival”. The Journal of Clinical Investigation 107 (9): 1055–1061. doi:10.1172/JCI12980. PMC 209291. PMID 11342566.
Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R (September 2006). “Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death”. Journal of Cellular Physiology 208 (3): 629–639. doi:10.1002/jcp.20701. PMID 16741956.
Fisher LW, Fedarko NS (2003). “Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins”. Connective Tissue Research 44 (Suppl 1): 33–40. doi:10.1080/03008200390152061. PMID 12952171.
Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES (August 2005). “Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications”. The Biochemical Journal 390 (Pt 1): 285–292. doi:10.1042/BJ20050341. PMC 1184582. PMID 15869464.
David V, Martin A, Hedge AM, Drezner MK, Rowe PS (March 2011). “ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate”. American Journal of Physiology. Renal Physiology 300 (3): F783–F791. doi:10.1152/ajprenal.00304.2010. PMC 3064126. PMID 21177780.
Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (April 2008). “Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP”. Endocrinology 149 (4): 1757–1772. doi:10.1210/en.2007-1205. PMC 2276704. PMID 18162525.
Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (October 2008). “MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM”. Journal of Bone and Mineral Research 23 (10): 1638–1649. doi:10.1359/jbmr.080601. PMID 18597632.
Addison WN, Masica DL, Gray JJ, McKee MD (April 2010). “Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage”. Journal of Bone and Mineral Research 25 (4): 695–705. doi:10.1359/jbmr.090832. PMID 19775205.
Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (August 2013). “Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin”. Biochemistry 52 (31): 5167–5175. doi:10.1021/bi400502c. PMC 3737600. PMID 23848319.
Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). “Roles of electrostatics and conformation in protein-crystal interactions”. PLOS ONE 5 (2): e9330. Bibcode: 2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
Hunter GK, O'Young J, Grohe B, Karttunen M, Goldberg HA (December 2010). “The flexible polyelectrolyte hypothesis of protein-biomineral interaction”. Langmuir 26 (24): 18639–18646. doi:10.1021/la100401r. PMID 20527831.
McKee MD, Nanci A (May 1995). “Postembedding colloidal-gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues”. Microscopy Research and Technique 31 (1): 44–62. doi:10.1002/jemt.1070310105. PMID 7626799.
Takemura T, Sakagami M, Nakase T, Kubo T, Kitamura Y, Nomura S (September 1994). “Localization of osteopontin in the otoconial organs of adult rats”. Hearing Research 79 (1–2): 99–104. doi:10.1016/0378-5955(94)90131-7. PMID 7806488.
Hincke MT, Nys Y, Gautron J, Mann K, Rodriguez-Navarro AB, McKee MD (January 2012). “The eggshell: structure, composition and mineralization”. Frontiers in Bioscience 17 (4): 1266–1280. doi:10.2741/3985. PMID 22201802.
McKee MD, Nanci A, Khan SR (December 1995). “Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi”. Journal of Bone and Mineral Research 10 (12): 1913–1929. doi:10.1002/jbmr.5650101211. PMID 8619372.
O'Young J, Chirico S, Al Tarhuni N, Grohe B, Karttunen M, Goldberg HA, Hunter GK (2009). “Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals”. Cells Tissues Organs 189 (1–4): 51–55. doi:10.1159/000151724. PMID 18728346.
Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, McKee MD (August 2009). “Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning”. The Journal of Biological Chemistry 284 (35): 23491–23501. doi:10.1074/jbc.M109.021899. PMC 2749123. PMID 19581305.
Sodek J, Ganss B, McKee MD (2000). “Osteopontin”. Critical Reviews in Oral Biology and Medicine 11 (3): 279–303. doi:10.1177/10454411000110030101. PMID 11021631.
Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NM, McKee MD (September 2020). “Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix”. Bone 138: 115447. doi:10.1016/j.bone.2020.115447. PMID 32454257.
McKee MD, Buss DJ, Reznikov N (March 2022). “Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization”. Journal of Structural Biology 214 (1): 107823. doi:10.1016/j.jsb.2021.107823. PMID 34915130.
McKee MD, Hoac B, Addison WN, Barros NM, Millán JL, Chaussain C (October 2013). “Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia”. Periodontology 2000 63 (1): 102–122. doi:10.1111/prd.12029. PMC 3766584. PMID 23931057.
Boukpessi T, Hoac B, Coyac BR, Leger T, Garcia C, Wicart P, Whyte MP, Glorieux FH, Linglart A, Chaussain C, McKee MD (February 2017). “Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia”. Bone 95: 151–161. doi:10.1016/j.bone.2016.11.019. PMID 27884786.
Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NM, McKee MD (September 2020). “Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix”. Bone 138: 115447. doi:10.1016/j.bone.2020.115447. PMID 32454257.
McKee MD, Addison WN, Kaartinen MT (2005). “Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton”. Cells Tissues Organs 181 (3–4): 176–188. doi:10.1159/000091379. PMID 16612083.
Kaartinen MT, Murshed M, Karsenty G, McKee MD (April 2007). “Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice”. The Journal of Histochemistry and Cytochemistry 55 (4): 375–386. doi:10.1369/jhc.6A7087.2006. PMID 17189522.
Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (December 2002). “Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification”. The American Journal of Pathology 161 (6): 2035–2046. doi:10.1016/S0002-9440(10)64482-3. PMC 1850905. PMID 12466120.
Giachelli CM (March 1999). “Ectopic calcification: gathering hard facts about soft tissue mineralization”. The American Journal of Pathology 154 (3): 671–675. doi:10.1016/S0002-9440(10)65313-8. PMC 1866412. PMID 10079244.
Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK (December 2008). “Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis”. Rheumatology 47 (12): 1775–1779. doi:10.1093/rheumatology/ken385. PMID 18854347.
McKee MD, Nanci A (1996). “Osteopontin: an interfacial extracellular matrix protein in mineralized tissues”. Connective Tissue Research 35 (1–4): 197–205. doi:10.3109/03008209609029192. PMID 9084658.
Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S (February 2008). “Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells”. European Journal of Immunology 38 (2): 489–499. doi:10.1002/eji.200737057. PMID 18200503.
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK (August 2005). “Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis”. Toxicology and Applied Pharmacology 207 (1): 25–38. doi:10.1016/j.taap.2004.12.018. PMID 15885730.
Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, Glogauer M, Sodek J, Zohar R (December 2007). “Role of osteopontin in neutrophil function”. Immunology 122 (4): 466–475. doi:10.1111/j.1365-2567.2007.02682.x. PMC 2266047. PMID 17680800.
Ohshima S, Kobayashi H, Yamaguchi N, Nishioka K, Umeshita-Sasai M, Mima T, Nomura S, Kon S, Inobe M, Uede T, Saeki Y (April 2002). “Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis”. Arthritis and Rheumatism 46 (4): 1094–1101. doi:10.1002/art.10143. PMID 11953989.
Burdo TH, Wood MR, Fox HS (June 2007). “Osteopontin prevents monocyte recirculation and apoptosis”. Journal of Leukocyte Biology 81 (6): 1504–1511. doi:10.1189/jlb.1106711. PMC 2490714. PMID 17369493.
Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (April 2002). “Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice”. Proceedings of the National Academy of Sciences of the United States of America 99 (7): 4556–4561. Bibcode: 2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
Jacobs JP, Pettit AR, Shinohara ML, Jansson M, Cantor H, Gravallese EM, Mathis D, Benoist C (August 2004). “Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis”. Arthritis and Rheumatism 50 (8): 2685–2694. doi:10.1002/art.20381. PMID 15334485.
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L (November 2001). “The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease”. Science 294 (5547): 1731–1735. Bibcode: 2001Sci...294.1731C. doi:10.1126/science.1062960. PMID 11721059.
Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, Lambrecht BN, Lloyd CM, Panoutsakopoulou V (May 2007). “Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets”. Nature Medicine 13 (5): 570–578. doi:10.1038/nm1580. PMC 3384679. PMID 17435770.
Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C (May 2009). “Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma”. American Journal of Respiratory and Critical Care Medicine 179 (10): 894–902. doi:10.1164/rccm.200807-1081OC. PMID 19234104.
Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, Gogos H, Economidou E, Lötvall J, Xanthou G, Panoutsakopoulou V, Gaga M (February 2011). “Osteopontin expression and relation to disease severity in human asthma”. The European Respiratory Journal 37 (2): 331–341. doi:10.1183/09031936.00017810. PMID 20562127.
Hillas G, Loukides S, Kostikas K, Simoes D, Petta V, Konstantellou E, Emmanouil P, Papiris S, Koulouris N, Bakakos P (January 2013). “Increased levels of osteopontin in sputum supernatant of smoking asthmatics”. Cytokine 61 (1): 251–255. doi:10.1016/j.cyto.2012.10.002. PMID 23098767.
Samitas K, Zervas E, Xanthou G, Panoutsakopoulou V, Gaga M (March 2013). “Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics”. Cytokine 61 (3): 713–715. doi:10.1016/j.cyto.2012.12.028. PMID 23384656.
Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF, Geiger H, Obermüller N (November 2002). “Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum”. Scandinavian Journal of Gastroenterology 37 (11): 1286–1295. doi:10.1080/003655202761020560. PMID 12465727.
Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T (September 2005). “Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response”. Gut 54 (9): 1254–1262. doi:10.1136/gut.2004.048298. PMC 1774642. PMID 16099792.
Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, Omagari K, Mizuta Y, Ozono Y, Kohno S (February 2007). “High plasma osteopontin levels in patients with inflammatory bowel disease”. Journal of Clinical Gastroenterology 41 (2): 167–172. doi:10.1097/MCG.0b013e31802d6268. PMID 17245215.
Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). “Osteopontin expression by CD103- dendritic cells drives intestinal inflammation”. Proceedings of the National Academy of Sciences of the United States of America 111 (9): E856–E865. Bibcode: 2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
Steinman L (February 2007). “A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage”. Nature Medicine 13 (2): 139–145. doi:10.1038/nm1551. PMID 17290272.
Clay R, Siddiqi SA (January 2019). “Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer” (英語). Theranostic Approach for Pancreatic Cancer: 325–367. doi:10.1016/B978-0-12-819457-7.00016-5. ISBN 9780128194577.
Clay R, Siddiqi SA (2019-01-01). “Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer” (英語). Theranostic Approach for Pancreatic Cancer: 325–367. doi:10.1016/B978-0-12-819457-7.00016-5. ISBN 9780128194577.
Mori R, Shaw TJ, Martin P (January 2008). “Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring”. The Journal of Experimental Medicine 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
- “Gel 'to speed up wound healing'”. BBC News. (2008年1月22日)
- Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, Simmons BH, Wu A, Lee JH, Bergqvist S, Kraynov E (March 2012). “Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer”. Journal of Experimental & Clinical Cancer Research 31 (1): 26. doi:10.1186/1756-9966-31-26. PMC 3325875. PMID 22444159.
- Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). “Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities”. Scientific Reports 8 (1): 7781. Bibcode: 2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
- Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H. Intracellular osteopontin regulates homeostasis and function of natural killer cells. Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):494-9. doi:10.1073/pnas.1423011112. Epub 2014 Dec 30. PMID 25550515; PMC 4299239.
- Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest. 2012 Feb;122(2):575-85. doi:10.1172/JCI61034. Epub 2012 Jan 17. PMID 22251703; PMC 3266798.
- Davina Camargo Madeira Simoes, Nikolaos Paschalidis, Evangelia Kourepini, Vily Panoutsakopoulou; An integrin axis induces IFN-β production in plasmacytoid dendritic cells. J Cell Biol 5 September 2022; 221 (9): e202102055. doi:10.1083/jcb.202102055.
- Singh M, Dalal S, Singh K (November 2014). “Osteopontin: At the cross-roads of myocyte survival and myocardial function”. Life Sciences 118 (1): 1–6. doi:10.1016/j.lfs.2014.09.014. PMC 4254317. PMID 25265596.
- Singh M, Foster CR, Dalal S, Singh K (March 2010). “Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI”. Journal of Molecular and Cellular Cardiology 48 (3): 538–543. doi:10.1016/j.yjmcc.2009.06.015. PMC 2823840. PMID 19573532.
- Shirakawa K, Sano M (July 2021). “Osteopontin in Cardiovascular Diseases”. Biomolecules 11 (7): 1047. doi:10.3390/biom11071047. PMC 8301767. PMID 34356671.
- Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, Hsueh WA (November 1997). “Myocardial osteopontin expression is associated with left ventricular hypertrophy”. Circulation 96 (9): 3063–3071. doi:10.1161/01.CIR.96.9.3063. PMID 9386176.
- Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C (March 2007). “Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model”. Neurobiology of Disease 25 (3): 473–482. doi:10.1016/j.nbd.2006.10.020. PMID 17188882.
- Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W, Andrade FH (February 2002). “A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice”. Human Molecular Genetics 11 (3): 263–272. doi:10.1093/hmg/11.3.263. PMID 11823445.
- Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM (November 2002). “Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle”. Proceedings of the National Academy of Sciences of the United States of America 99 (23): 15000–15005. Bibcode: 2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.
- Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, Motoyoshi K, Kamakura K, Miyagoe-Suzuki Y, Takeda S (July 2003). “Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin”. The American Journal of Pathology 163 (1): 203–215. doi:10.1016/S0002-9440(10)63644-9. PMC 1868192. PMID 12819025.
- Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, Miceli MC, Spencer MJ (June 2009). “Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta”. The Journal of Clinical Investigation 119 (6): 1583–1594. doi:10.1172/JCI37662. PMC 2689112. PMID 19451692.
- Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM (January 2011). “SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy”. Neurology 76 (3): 219–226. doi:10.1212/WNL.0b013e318207afeb. PMC 3034396. PMID 21178099.
- El Deeb S, Abdelnaby R, Khachab A, Bläsius K, Tingart M, Rath B (July 2016). “Osteopontin as a biochemical marker and severity indicator for idiopathic hip osteoarthritis”. Hip International 26 (4): 397–403. doi:10.5301/hipint.5000361. PMID 27229171.
- Kang YJ, Forbes K, Carver J, Aplin JD (April 2014). “The role of the osteopontin-integrin αvβ3 interaction at implantation: functional analysis using three different in vitro models”. Human Reproduction 29 (4): 739–749. doi:10.1093/humrep/det433. PMID 24442579.
- Johnson GA, Burghardt RC, Bazer FW, Spencer TE (November 2003). “Osteopontin: roles in implantation and placentation”. Biology of Reproduction 69 (5): 1458–1471. doi:10.1095/biolreprod.103.020651. PMID 12890718.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000118785 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000029304 - Ensembl, May 2017

harvard.edu

ui.adsabs.harvard.edu

Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). “Osteopontin--a possible anchor of osteoclasts to bone”. Proceedings of the National Academy of Sciences of the United States of America 87 (12): 4473–4475. Bibcode: 1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). “Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells”. Proceedings of the National Academy of Sciences of the United States of America 105 (20): 7235–7239. Bibcode: 2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). “Roles of electrostatics and conformation in protein-crystal interactions”. PLOS ONE 5 (2): e9330. Bibcode: 2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (April 2002). “Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice”. Proceedings of the National Academy of Sciences of the United States of America 99 (7): 4556–4561. Bibcode: 2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L (November 2001). “The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease”. Science 294 (5547): 1731–1735. Bibcode: 2001Sci...294.1731C. doi:10.1126/science.1062960. PMID 11721059.
Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). “Osteopontin expression by CD103- dendritic cells drives intestinal inflammation”. Proceedings of the National Academy of Sciences of the United States of America 111 (9): E856–E865. Bibcode: 2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). “Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities”. Scientific Reports 8 (1): 7781. Bibcode: 2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM (November 2002). “Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle”. Proceedings of the National Academy of Sciences of the United States of America 99 (23): 15000–15005. Bibcode: 2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.

hpcr.jp

bibgraph.hpcr.jp

Osada, Manabu. “初期のTリンパ球活性化1（Eta-1）タンパク質とin vitroでのマウスマクロファージ間の特異的相互作用の定義とin vivoでのマクロファージへの影響 - Bibgraph（ビブグラフ）| PubMedを日本語で論文検索”. Bibgraph（ビブグラフ）. 2024年2月18日閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

Kalmar L, Homola D, Varga G, Tompa P (September 2012). “Structural disorder in proteins brings order to crystal growth in biomineralization”. Bone 51 (3): 528–534. doi:10.1016/j.bone.2012.05.009. PMID 22634174.
Wang KX, Denhardt DT (2008). “Osteopontin: role in immune regulation and stress responses”. Cytokine & Growth Factor Reviews 19 (5–6): 333–345. doi:10.1016/j.cytogfr.2008.08.001. PMID 18952487.
Rangaswami H, Bulbule A, Kundu GC (February 2006). “Osteopontin: role in cell signaling and cancer progression”. Trends in Cell Biology 16 (2): 79–87. doi:10.1016/j.tcb.2005.12.005. PMID 16406521.
Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (August 1990). “cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)”. Genomics 7 (4): 491–502. doi:10.1016/0888-7543(90)90191-V. PMID 1974876. https://zenodo.org/record/1258571.
Kiefer MC, Bauer DM, Barr PJ (April 1989). “The cDNA and derived amino acid sequence for human osteopontin”. Nucleic Acids Research 17 (8): 3306. doi:10.1093/nar/17.8.3306. PMC 317745. PMID 2726470.
Crosby AH, Edwards SJ, Murray JC, Dixon MJ (May 1995). “Genomic organization of the human osteopontin gene: exclusion of the locus from a causative role in the pathogenesis of dentinogenesis imperfecta type II”. Genomics 27 (1): 155–160. doi:10.1006/geno.1995.1018. PMID 7665163.
Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, Carmona AK, McKee MD (March 2013). “Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia”. Journal of Bone and Mineral Research 28 (3): 688–699. doi:10.1002/jbmr.1766. PMID 22991293.
Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F (August 1991). “Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis”. The Journal of Clinical Investigation 88 (2): 546–552. doi:10.1172/JCI115338. PMC 295383. PMID 1830891.
Seiffge D (December 1996). “Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats”. The Journal of Rheumatology 23 (12): 2086–2091. PMID 8970045.
Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). “Osteopontin--a possible anchor of osteoclasts to bone”. Proceedings of the National Academy of Sciences of the United States of America 87 (12): 4473–4475. Bibcode: 1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
Banerjee A, Apte UM, Smith R, Ramaiah SK (March 2006). “Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease”. The Journal of Pathology 208 (4): 473–485. doi:10.1002/path.1917. PMID 16440289.
Sodek J, Batista Da Silva AP, Zohar R (May 2006). “Osteopontin and mucosal protection”. Journal of Dental Research 85 (5): 404–415. doi:10.1177/154405910608500503. PMID 16632752. ^{[リンク切れ]}
Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (July 2000). “Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration”. Journal of Cellular Physiology 184 (1): 118–130. doi:10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y. PMID 10825241.
Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J (August 2002). “Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts”. Journal of Bone and Mineral Research 17 (8): 1486–1497. doi:10.1359/jbmr.2002.17.8.1486. PMID 12162503.
Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J (January 2004). “Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin”. Journal of Cellular Physiology 198 (1): 155–167. doi:10.1002/jcp.10394. PMID 14584055.
Junaid A, Moon MC, Harding GE, Zahradka P (February 2007). “Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1”. American Journal of Physiology. Cell Physiology 292 (2): C919–C926. doi:10.1152/ajpcell.00477.2006. PMID 17005603.
Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). “Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells”. Proceedings of the National Academy of Sciences of the United States of America 105 (20): 7235–7239. Bibcode: 2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
He B, Mirza M, Weber GF (April 2006). “An osteopontin splice variant induces anchorage independence in human breast cancer cells”. Oncogene 25 (15): 2192–2202. doi:10.1038/sj.onc.1209248. PMID 16288209.
Mirza M, Shaughnessy E, Hurley JK, Vanpatten KA, Pestano GA, He B, Weber GF (February 2008). “Osteopontin-c is a selective marker of breast cancer”. International Journal of Cancer 122 (4): 889–897. doi:10.1002/ijc.23204. PMID 17960616.
Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA (November 1996). “Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction”. The Journal of Clinical Investigation 98 (10): 2218–2227. doi:10.1172/JCI119031. PMC 507670. PMID 8941637.
Murry CE, Giachelli CM, Schwartz SM, Vracko R (December 1994). “Macrophages express osteopontin during repair of myocardial necrosis”. The American Journal of Pathology 145 (6): 1450–1462. PMC 1887495. PMID 7992848.
Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K (December 1993). “Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta”. The Journal of Clinical Investigation 92 (6): 2814–2820. doi:10.1172/JCI116901. PMC 288482. PMID 8254036.
Uaesoontrachoon K, Yoo HJ, Tudor EM, Pike RN, Mackie EJ, Pagel CN (April 2008). “Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro”. The International Journal of Biochemistry & Cell Biology 40 (10): 2303–2314. doi:10.1016/j.biocel.2008.03.020. PMID 18490187.
Merry K, Dodds R, Littlewood A, Gowen M (April 1993). “Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone”. Journal of Cell Science 104 (4): 1013–1020. doi:10.1242/jcs.104.4.1013. PMID 8314886.
Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B (January 2002). “The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation”. Cell 108 (1): 17–29. doi:10.1016/S0092-8674(01)00622-5. PMID 11792318.
Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (May 1997). “Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation”. Cell 89 (5): 747–754. doi:10.1016/S0092-8674(00)80257-3. PMID 9182762.
Yucha C, Guthrie D (December 2003). “Renal homeostasis of calcium”. Nephrology Nursing Journal 30 (6): 755–764. PMID 14730782.
Prince CW, Butler WT (September 1987). “1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells”. Collagen and Related Research 7 (4): 305–313. doi:10.1016/s0174-173x(87)80036-5. PMID 3478171.
Oldberg A, Jirskog-Hed B, Axelsson S, Heinegård D (December 1989). “Regulation of bone sialoprotein mRNA by steroid hormones”. The Journal of Cell Biology 109 (6 Pt 1): 3183–3186. doi:10.1083/jcb.109.6.3183. PMC 2115918. PMID 2592421.
Chang PL, Prince CW (April 1991). “1 alpha,25-dihydroxyvitamin D3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells”. Cancer Research 51 (8): 2144–2150. PMID 2009532.
Pereira TA, Vaz de Melo Trindade G, Trindade Santos E, Pereira FE, Souza MM (May 2021). “Praziquantel pharmacotherapy reduces systemic osteopontin levels and liver collagen content in murine schistosomiasis mansoni”. International Journal for Parasitology 51 (6): 437–440. doi:10.1016/j.ijpara.2020.11.002. PMID 33493521.
Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (January 2009). “Phosphate regulates osteopontin gene transcription”. Journal of Dental Research 88 (1): 39–44. doi:10.1177/0022034508328072. PMC 3128439. PMID 19131315.
Guo H, Cai CQ, Schroeder RA, Kuo PC (January 2001). “Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages”. Journal of Immunology 166 (2): 1079–1086. doi:10.4049/jimmunol.166.2.1079. PMID 11145688.
Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR (May 2000). “Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells”. American Journal of Physiology. Renal Physiology 278 (5): F708–F716. doi:10.1152/ajprenal.2000.278.5.F708. PMID 10807582.
Noda M, Rodan GA (February 1989). “Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone”. The Journal of Cell Biology 108 (2): 713–718. doi:10.1083/jcb.108.2.713. PMC 2115413. PMID 2465299.
Hullinger TG, Pan Q, Viswanathan HL, Somerman MJ (January 2001). “TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements”. Experimental Cell Research 262 (1): 69–74. doi:10.1006/excr.2000.5074. PMID 11120606.
Sodhi CP, Phadke SA, Batlle D, Sahai A (April 2001). “Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin”. American Journal of Physiology. Renal Physiology 280 (4): F667–F674. doi:10.1152/ajprenal.2001.280.4.F667. PMID 11249858.
Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (May 2001). “Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival”. The Journal of Clinical Investigation 107 (9): 1055–1061. doi:10.1172/JCI12980. PMC 209291. PMID 11342566.
Standal T, Borset M, Sundan A (September 2004). “Role of osteopontin in adhesion, migration, cell survival and bone remodeling”. Experimental Oncology 26 (3): 179–184. PMID 15494684.
Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R (September 2006). “Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death”. Journal of Cellular Physiology 208 (3): 629–639. doi:10.1002/jcp.20701. PMID 16741956.
Fisher LW, Fedarko NS (2003). “Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins”. Connective Tissue Research 44 (Suppl 1): 33–40. doi:10.1080/03008200390152061. PMID 12952171.
Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES (August 2005). “Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications”. The Biochemical Journal 390 (Pt 1): 285–292. doi:10.1042/BJ20050341. PMC 1184582. PMID 15869464.
David V, Martin A, Hedge AM, Drezner MK, Rowe PS (March 2011). “ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate”. American Journal of Physiology. Renal Physiology 300 (3): F783–F791. doi:10.1152/ajprenal.00304.2010. PMC 3064126. PMID 21177780.
Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (April 2008). “Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP”. Endocrinology 149 (4): 1757–1772. doi:10.1210/en.2007-1205. PMC 2276704. PMID 18162525.
Addison WN, Nakano Y, Loisel T, Crine P, McKee MD (October 2008). “MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM”. Journal of Bone and Mineral Research 23 (10): 1638–1649. doi:10.1359/jbmr.080601. PMID 18597632.
Addison WN, Masica DL, Gray JJ, McKee MD (April 2010). “Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage”. Journal of Bone and Mineral Research 25 (4): 695–705. doi:10.1359/jbmr.090832. PMID 19775205.
Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (August 2013). “Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin”. Biochemistry 52 (31): 5167–5175. doi:10.1021/bi400502c. PMC 3737600. PMID 23848319.
Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). “Roles of electrostatics and conformation in protein-crystal interactions”. PLOS ONE 5 (2): e9330. Bibcode: 2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
Hunter GK, O'Young J, Grohe B, Karttunen M, Goldberg HA (December 2010). “The flexible polyelectrolyte hypothesis of protein-biomineral interaction”. Langmuir 26 (24): 18639–18646. doi:10.1021/la100401r. PMID 20527831.
McKee MD, Nanci A (May 1995). “Postembedding colloidal-gold immunocytochemistry of noncollagenous extracellular matrix proteins in mineralized tissues”. Microscopy Research and Technique 31 (1): 44–62. doi:10.1002/jemt.1070310105. PMID 7626799.
Takemura T, Sakagami M, Nakase T, Kubo T, Kitamura Y, Nomura S (September 1994). “Localization of osteopontin in the otoconial organs of adult rats”. Hearing Research 79 (1–2): 99–104. doi:10.1016/0378-5955(94)90131-7. PMID 7806488.
Hincke MT, Nys Y, Gautron J, Mann K, Rodriguez-Navarro AB, McKee MD (January 2012). “The eggshell: structure, composition and mineralization”. Frontiers in Bioscience 17 (4): 1266–1280. doi:10.2741/3985. PMID 22201802.
McKee MD, Nanci A, Khan SR (December 1995). “Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi”. Journal of Bone and Mineral Research 10 (12): 1913–1929. doi:10.1002/jbmr.5650101211. PMID 8619372.
O'Young J, Chirico S, Al Tarhuni N, Grohe B, Karttunen M, Goldberg HA, Hunter GK (2009). “Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals”. Cells Tissues Organs 189 (1–4): 51–55. doi:10.1159/000151724. PMID 18728346.
Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, McKee MD (August 2009). “Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning”. The Journal of Biological Chemistry 284 (35): 23491–23501. doi:10.1074/jbc.M109.021899. PMC 2749123. PMID 19581305.
Sodek J, Ganss B, McKee MD (2000). “Osteopontin”. Critical Reviews in Oral Biology and Medicine 11 (3): 279–303. doi:10.1177/10454411000110030101. PMID 11021631.
Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NM, McKee MD (September 2020). “Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix”. Bone 138: 115447. doi:10.1016/j.bone.2020.115447. PMID 32454257.
McKee MD, Buss DJ, Reznikov N (March 2022). “Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization”. Journal of Structural Biology 214 (1): 107823. doi:10.1016/j.jsb.2021.107823. PMID 34915130.
McKee MD, Hoac B, Addison WN, Barros NM, Millán JL, Chaussain C (October 2013). “Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia”. Periodontology 2000 63 (1): 102–122. doi:10.1111/prd.12029. PMC 3766584. PMID 23931057.
Boukpessi T, Hoac B, Coyac BR, Leger T, Garcia C, Wicart P, Whyte MP, Glorieux FH, Linglart A, Chaussain C, McKee MD (February 2017). “Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia”. Bone 95: 151–161. doi:10.1016/j.bone.2016.11.019. PMID 27884786.
Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NM, McKee MD (September 2020). “Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix”. Bone 138: 115447. doi:10.1016/j.bone.2020.115447. PMID 32454257.
McKee MD, Addison WN, Kaartinen MT (2005). “Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton”. Cells Tissues Organs 181 (3–4): 176–188. doi:10.1159/000091379. PMID 16612083.
Kaartinen MT, Murshed M, Karsenty G, McKee MD (April 2007). “Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice”. The Journal of Histochemistry and Cytochemistry 55 (4): 375–386. doi:10.1369/jhc.6A7087.2006. PMID 17189522.
Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (December 2002). “Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification”. The American Journal of Pathology 161 (6): 2035–2046. doi:10.1016/S0002-9440(10)64482-3. PMC 1850905. PMID 12466120.
Giachelli CM (March 1999). “Ectopic calcification: gathering hard facts about soft tissue mineralization”. The American Journal of Pathology 154 (3): 671–675. doi:10.1016/S0002-9440(10)65313-8. PMC 1866412. PMID 10079244.
Choi ST, Kim JH, Kang EJ, Lee SW, Park MC, Park YB, Lee SK (December 2008). “Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis”. Rheumatology 47 (12): 1775–1779. doi:10.1093/rheumatology/ken385. PMID 18854347.
McKee MD, Nanci A (1996). “Osteopontin: an interfacial extracellular matrix protein in mineralized tissues”. Connective Tissue Research 35 (1–4): 197–205. doi:10.3109/03008209609029192. PMID 9084658.
Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S (February 2008). “Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells”. European Journal of Immunology 38 (2): 489–499. doi:10.1002/eji.200737057. PMID 18200503.
Crawford HC, Matrisian LM, Liaw L (November 1998). “Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo”. Cancer Research 58 (22): 5206–5215. PMID 9823334.
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK (August 2005). “Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis”. Toxicology and Applied Pharmacology 207 (1): 25–38. doi:10.1016/j.taap.2004.12.018. PMID 15885730.
Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, Glogauer M, Sodek J, Zohar R (December 2007). “Role of osteopontin in neutrophil function”. Immunology 122 (4): 466–475. doi:10.1111/j.1365-2567.2007.02682.x. PMC 2266047. PMID 17680800.
Ohshima S, Kobayashi H, Yamaguchi N, Nishioka K, Umeshita-Sasai M, Mima T, Nomura S, Kon S, Inobe M, Uede T, Saeki Y (April 2002). “Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis”. Arthritis and Rheumatism 46 (4): 1094–1101. doi:10.1002/art.10143. PMID 11953989.
Sakata M, Tsuruha JI, Masuko-Hongo K, Nakamura H, Matsui T, Sudo A, Nishioka K, Kato T (July 2001). “Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis”. The Journal of Rheumatology 28 (7): 1492–1495. PMID 11469452.
Burdo TH, Wood MR, Fox HS (June 2007). “Osteopontin prevents monocyte recirculation and apoptosis”. Journal of Leukocyte Biology 81 (6): 1504–1511. doi:10.1189/jlb.1106711. PMC 2490714. PMID 17369493.
Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (April 2002). “Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice”. Proceedings of the National Academy of Sciences of the United States of America 99 (7): 4556–4561. Bibcode: 2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
Jacobs JP, Pettit AR, Shinohara ML, Jansson M, Cantor H, Gravallese EM, Mathis D, Benoist C (August 2004). “Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis”. Arthritis and Rheumatism 50 (8): 2685–2694. doi:10.1002/art.20381. PMID 15334485.
Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L (November 2001). “The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease”. Science 294 (5547): 1731–1735. Bibcode: 2001Sci...294.1731C. doi:10.1126/science.1062960. PMID 11721059.
Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, Lambrecht BN, Lloyd CM, Panoutsakopoulou V (May 2007). “Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets”. Nature Medicine 13 (5): 570–578. doi:10.1038/nm1580. PMC 3384679. PMID 17435770.
Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C (May 2009). “Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma”. American Journal of Respiratory and Critical Care Medicine 179 (10): 894–902. doi:10.1164/rccm.200807-1081OC. PMID 19234104.
Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, Gogos H, Economidou E, Lötvall J, Xanthou G, Panoutsakopoulou V, Gaga M (February 2011). “Osteopontin expression and relation to disease severity in human asthma”. The European Respiratory Journal 37 (2): 331–341. doi:10.1183/09031936.00017810. PMID 20562127.
Hillas G, Loukides S, Kostikas K, Simoes D, Petta V, Konstantellou E, Emmanouil P, Papiris S, Koulouris N, Bakakos P (January 2013). “Increased levels of osteopontin in sputum supernatant of smoking asthmatics”. Cytokine 61 (1): 251–255. doi:10.1016/j.cyto.2012.10.002. PMID 23098767.
Samitas K, Zervas E, Xanthou G, Panoutsakopoulou V, Gaga M (March 2013). “Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics”. Cytokine 61 (3): 713–715. doi:10.1016/j.cyto.2012.12.028. PMID 23384656.
Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF, Geiger H, Obermüller N (November 2002). “Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum”. Scandinavian Journal of Gastroenterology 37 (11): 1286–1295. doi:10.1080/003655202761020560. PMID 12465727.
Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T (September 2005). “Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response”. Gut 54 (9): 1254–1262. doi:10.1136/gut.2004.048298. PMC 1774642. PMID 16099792.
Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, Omagari K, Mizuta Y, Ozono Y, Kohno S (February 2007). “High plasma osteopontin levels in patients with inflammatory bowel disease”. Journal of Clinical Gastroenterology 41 (2): 167–172. doi:10.1097/MCG.0b013e31802d6268. PMID 17245215.
Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). “Osteopontin expression by CD103- dendritic cells drives intestinal inflammation”. Proceedings of the National Academy of Sciences of the United States of America 111 (9): E856–E865. Bibcode: 2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
Steinman L (February 2007). “A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage”. Nature Medicine 13 (2): 139–145. doi:10.1038/nm1551. PMID 17290272.
Mori R, Shaw TJ, Martin P (January 2008). “Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring”. The Journal of Experimental Medicine 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
- “Gel 'to speed up wound healing'”. BBC News. (2008年1月22日)
- Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, Simmons BH, Wu A, Lee JH, Bergqvist S, Kraynov E (March 2012). “Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer”. Journal of Experimental & Clinical Cancer Research 31 (1): 26. doi:10.1186/1756-9966-31-26. PMC 3325875. PMID 22444159.
- Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). “Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities”. Scientific Reports 8 (1): 7781. Bibcode: 2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
- Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H. Intracellular osteopontin regulates homeostasis and function of natural killer cells. Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):494-9. doi:10.1073/pnas.1423011112. Epub 2014 Dec 30. PMID 25550515; PMC 4299239.
- Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest. 2012 Feb;122(2):575-85. doi:10.1172/JCI61034. Epub 2012 Jan 17. PMID 22251703; PMC 3266798.
- Singh M, Dalal S, Singh K (November 2014). “Osteopontin: At the cross-roads of myocyte survival and myocardial function”. Life Sciences 118 (1): 1–6. doi:10.1016/j.lfs.2014.09.014. PMC 4254317. PMID 25265596.
- Singh M, Foster CR, Dalal S, Singh K (March 2010). “Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI”. Journal of Molecular and Cellular Cardiology 48 (3): 538–543. doi:10.1016/j.yjmcc.2009.06.015. PMC 2823840. PMID 19573532.
- Shirakawa K, Sano M (July 2021). “Osteopontin in Cardiovascular Diseases”. Biomolecules 11 (7): 1047. doi:10.3390/biom11071047. PMC 8301767. PMID 34356671.
- Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, Hsueh WA (November 1997). “Myocardial osteopontin expression is associated with left ventricular hypertrophy”. Circulation 96 (9): 3063–3071. doi:10.1161/01.CIR.96.9.3063. PMID 9386176.
- Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C (March 2007). “Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model”. Neurobiology of Disease 25 (3): 473–482. doi:10.1016/j.nbd.2006.10.020. PMID 17188882.
- Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, Leahy P, Li J, Guo W, Andrade FH (February 2002). “A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice”. Human Molecular Genetics 11 (3): 263–272. doi:10.1093/hmg/11.3.263. PMID 11823445.
- Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM (November 2002). “Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle”. Proceedings of the National Academy of Sciences of the United States of America 99 (23): 15000–15005. Bibcode: 2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.
- Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, Motoyoshi K, Kamakura K, Miyagoe-Suzuki Y, Takeda S (July 2003). “Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin”. The American Journal of Pathology 163 (1): 203–215. doi:10.1016/S0002-9440(10)63644-9. PMC 1868192. PMID 12819025.
- Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, Miceli MC, Spencer MJ (June 2009). “Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta”. The Journal of Clinical Investigation 119 (6): 1583–1594. doi:10.1172/JCI37662. PMC 2689112. PMID 19451692.
- Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM (January 2011). “SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy”. Neurology 76 (3): 219–226. doi:10.1212/WNL.0b013e318207afeb. PMC 3034396. PMID 21178099.
- El Deeb S, Abdelnaby R, Khachab A, Bläsius K, Tingart M, Rath B (July 2016). “Osteopontin as a biochemical marker and severity indicator for idiopathic hip osteoarthritis”. Hip International 26 (4): 397–403. doi:10.5301/hipint.5000361. PMID 27229171.
- Kang YJ, Forbes K, Carver J, Aplin JD (April 2014). “The role of the osteopontin-integrin αvβ3 interaction at implantation: functional analysis using three different in vitro models”. Human Reproduction 29 (4): 739–749. doi:10.1093/humrep/det433. PMID 24442579.
- Johnson GA, Burghardt RC, Bazer FW, Spencer TE (November 2003). “Osteopontin: roles in implantation and placentation”. Biology of Reproduction 69 (5): 1458–1471. doi:10.1095/biolreprod.103.020651. PMID 12890718.
ncbi.nlm.nih.gov
- Human PubMed Reference:
- Mouse PubMed Reference:
- “Entrez Gene: SPP1 secreted phosphoprotein 1”. 2024年2月18日閲覧。
- Kiefer MC, Bauer DM, Barr PJ (April 1989). “The cDNA and derived amino acid sequence for human osteopontin”. Nucleic Acids Research 17 (8): 3306. doi:10.1093/nar/17.8.3306. PMC 317745. PMID 2726470.
- Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F (August 1991). “Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis”. The Journal of Clinical Investigation 88 (2): 546–552. doi:10.1172/JCI115338. PMC 295383. PMID 1830891.
- Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). “Osteopontin--a possible anchor of osteoclasts to bone”. Proceedings of the National Academy of Sciences of the United States of America 87 (12): 4473–4475. Bibcode: 1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
- Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). “Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells”. Proceedings of the National Academy of Sciences of the United States of America 105 (20): 7235–7239. Bibcode: 2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
- Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA (November 1996). “Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction”. The Journal of Clinical Investigation 98 (10): 2218–2227. doi:10.1172/JCI119031. PMC 507670. PMID 8941637.
- Murry CE, Giachelli CM, Schwartz SM, Vracko R (December 1994). “Macrophages express osteopontin during repair of myocardial necrosis”. The American Journal of Pathology 145 (6): 1450–1462. PMC 1887495. PMID 7992848.
- Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K (December 1993). “Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta”. The Journal of Clinical Investigation 92 (6): 2814–2820. doi:10.1172/JCI116901. PMC 288482. PMID 8254036.
- Oldberg A, Jirskog-Hed B, Axelsson S, Heinegård D (December 1989). “Regulation of bone sialoprotein mRNA by steroid hormones”. The Journal of Cell Biology 109 (6 Pt 1): 3183–3186. doi:10.1083/jcb.109.6.3183. PMC 2115918. PMID 2592421.
- Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (January 2009). “Phosphate regulates osteopontin gene transcription”. Journal of Dental Research 88 (1): 39–44. doi:10.1177/0022034508328072. PMC 3128439. PMID 19131315.
- Noda M, Rodan GA (February 1989). “Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone”. The Journal of Cell Biology 108 (2): 713–718. doi:10.1083/jcb.108.2.713. PMC 2115413. PMID 2465299.
- Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (May 2001). “Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival”. The Journal of Clinical Investigation 107 (9): 1055–1061. doi:10.1172/JCI12980. PMC 209291. PMID 11342566.
- Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES (August 2005). “Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications”. The Biochemical Journal 390 (Pt 1): 285–292. doi:10.1042/BJ20050341. PMC 1184582. PMID 15869464.
- David V, Martin A, Hedge AM, Drezner MK, Rowe PS (March 2011). “ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate”. American Journal of Physiology. Renal Physiology 300 (3): F783–F791. doi:10.1152/ajprenal.00304.2010. PMC 3064126. PMID 21177780.
- Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (April 2008). “Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP”. Endocrinology 149 (4): 1757–1772. doi:10.1210/en.2007-1205. PMC 2276704. PMID 18162525.
- Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (August 2013). “Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin”. Biochemistry 52 (31): 5167–5175. doi:10.1021/bi400502c. PMC 3737600. PMID 23848319.
- Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). “Roles of electrostatics and conformation in protein-crystal interactions”. PLOS ONE 5 (2): e9330. Bibcode: 2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
- Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, McKee MD (August 2009). “Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning”. The Journal of Biological Chemistry 284 (35): 23491–23501. doi:10.1074/jbc.M109.021899. PMC 2749123. PMID 19581305.
- McKee MD, Hoac B, Addison WN, Barros NM, Millán JL, Chaussain C (October 2013). “Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia”. Periodontology 2000 63 (1): 102–122. doi:10.1111/prd.12029. PMC 3766584. PMID 23931057.
- Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (December 2002). “Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification”. The American Journal of Pathology 161 (6): 2035–2046. doi:10.1016/S0002-9440(10)64482-3. PMC 1850905. PMID 12466120.
- Giachelli CM (March 1999). “Ectopic calcification: gathering hard facts about soft tissue mineralization”. The American Journal of Pathology 154 (3): 671–675. doi:10.1016/S0002-9440(10)65313-8. PMC 1866412. PMID 10079244.
- Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, Glogauer M, Sodek J, Zohar R (December 2007). “Role of osteopontin in neutrophil function”. Immunology 122 (4): 466–475. doi:10.1111/j.1365-2567.2007.02682.x. PMC 2266047. PMID 17680800.
- Burdo TH, Wood MR, Fox HS (June 2007). “Osteopontin prevents monocyte recirculation and apoptosis”. Journal of Leukocyte Biology 81 (6): 1504–1511. doi:10.1189/jlb.1106711. PMC 2490714. PMID 17369493.
- Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (April 2002). “Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice”. Proceedings of the National Academy of Sciences of the United States of America 99 (7): 4556–4561. Bibcode: 2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
- Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, Lambrecht BN, Lloyd CM, Panoutsakopoulou V (May 2007). “Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets”. Nature Medicine 13 (5): 570–578. doi:10.1038/nm1580. PMC 3384679. PMID 17435770.
- Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T (September 2005). “Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response”. Gut 54 (9): 1254–1262. doi:10.1136/gut.2004.048298. PMC 1774642. PMID 16099792.
- Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). “Osteopontin expression by CD103- dendritic cells drives intestinal inflammation”. Proceedings of the National Academy of Sciences of the United States of America 111 (9): E856–E865. Bibcode: 2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
- Mori R, Shaw TJ, Martin P (January 2008). “Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring”. The Journal of Experimental Medicine 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
  - “Gel 'to speed up wound healing'”. BBC News. (2008年1月22日)
  - Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, Simmons BH, Wu A, Lee JH, Bergqvist S, Kraynov E (March 2012). “Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer”. Journal of Experimental & Clinical Cancer Research 31 (1): 26. doi:10.1186/1756-9966-31-26. PMC 3325875. PMID 22444159.
  - Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). “Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities”. Scientific Reports 8 (1): 7781. Bibcode: 2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
  - Singh M, Dalal S, Singh K (November 2014). “Osteopontin: At the cross-roads of myocyte survival and myocardial function”. Life Sciences 118 (1): 1–6. doi:10.1016/j.lfs.2014.09.014. PMC 4254317. PMID 25265596.
  - Singh M, Foster CR, Dalal S, Singh K (March 2010). “Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI”. Journal of Molecular and Cellular Cardiology 48 (3): 538–543. doi:10.1016/j.yjmcc.2009.06.015. PMC 2823840. PMID 19573532.
  - Shirakawa K, Sano M (July 2021). “Osteopontin in Cardiovascular Diseases”. Biomolecules 11 (7): 1047. doi:10.3390/biom11071047. PMC 8301767. PMID 34356671.
  - Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM (November 2002). “Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle”. Proceedings of the National Academy of Sciences of the United States of America 99 (23): 15000–15005. Bibcode: 2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.
  - Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, Motoyoshi K, Kamakura K, Miyagoe-Suzuki Y, Takeda S (July 2003). “Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin”. The American Journal of Pathology 163 (1): 203–215. doi:10.1016/S0002-9440(10)63644-9. PMC 1868192. PMID 12819025.
  - Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, Miceli MC, Spencer MJ (June 2009). “Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta”. The Journal of Clinical Investigation 119 (6): 1583–1594. doi:10.1172/JCI37662. PMC 2689112. PMID 19451692.
  - Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM (January 2011). “SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy”. Neurology 76 (3): 219–226. doi:10.1212/WNL.0b013e318207afeb. PMC 3034396. PMID 21178099.
  pmc.ncbi.nlm.nih.gov
  - Kiefer MC, Bauer DM, Barr PJ (April 1989). “The cDNA and derived amino acid sequence for human osteopontin”. Nucleic Acids Research 17 (8): 3306. doi:10.1093/nar/17.8.3306. PMC 317745. PMID 2726470.
  - Laffón A, García-Vicuña R, Humbría A, Postigo AA, Corbí AL, de Landázuri MO, Sánchez-Madrid F (August 1991). “Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis”. The Journal of Clinical Investigation 88 (2): 546–552. doi:10.1172/JCI115338. PMC 295383. PMID 1830891.
  - Reinholt FP, Hultenby K, Oldberg A, Heinegård D (June 1990). “Osteopontin--a possible anchor of osteoclasts to bone”. Proceedings of the National Academy of Sciences of the United States of America 87 (12): 4473–4475. Bibcode: 1990PNAS...87.4473R. doi:10.1073/pnas.87.12.4473. PMC 54137. PMID 1693772.
  - Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H (May 2008). “Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells”. Proceedings of the National Academy of Sciences of the United States of America 105 (20): 7235–7239. Bibcode: 2008PNAS..105.7235S. doi:10.1073/pnas.0802301105. PMC 2438233. PMID 18480255.
  - Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsueh WA (November 1996). “Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction”. The Journal of Clinical Investigation 98 (10): 2218–2227. doi:10.1172/JCI119031. PMC 507670. PMID 8941637.
  - Murry CE, Giachelli CM, Schwartz SM, Vracko R (December 1994). “Macrophages express osteopontin during repair of myocardial necrosis”. The American Journal of Pathology 145 (6): 1450–1462. PMC 1887495. PMID 7992848.
  - Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K (December 1993). “Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta”. The Journal of Clinical Investigation 92 (6): 2814–2820. doi:10.1172/JCI116901. PMC 288482. PMID 8254036.
  - Oldberg A, Jirskog-Hed B, Axelsson S, Heinegård D (December 1989). “Regulation of bone sialoprotein mRNA by steroid hormones”. The Journal of Cell Biology 109 (6 Pt 1): 3183–3186. doi:10.1083/jcb.109.6.3183. PMC 2115918. PMID 2592421.
  - Fatherazi S, Matsa-Dunn D, Foster BL, Rutherford RB, Somerman MJ, Presland RB (January 2009). “Phosphate regulates osteopontin gene transcription”. Journal of Dental Research 88 (1): 39–44. doi:10.1177/0022034508328072. PMC 3128439. PMID 19131315.
  - Noda M, Rodan GA (February 1989). “Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone”. The Journal of Cell Biology 108 (2): 713–718. doi:10.1083/jcb.108.2.713. PMC 2115413. PMID 2465299.
  - Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS (May 2001). “Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival”. The Journal of Clinical Investigation 107 (9): 1055–1061. doi:10.1172/JCI12980. PMC 209291. PMID 11342566.
  - Christensen B, Nielsen MS, Haselmann KF, Petersen TE, Sørensen ES (August 2005). “Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications”. The Biochemical Journal 390 (Pt 1): 285–292. doi:10.1042/BJ20050341. PMC 1184582. PMID 15869464.
  - David V, Martin A, Hedge AM, Drezner MK, Rowe PS (March 2011). “ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate”. American Journal of Physiology. Renal Physiology 300 (3): F783–F791. doi:10.1152/ajprenal.00304.2010. PMC 3064126. PMID 21177780.
  - Martin A, David V, Laurence JS, Schwarz PM, Lafer EM, Hedge AM, Rowe PS (April 2008). “Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP”. Endocrinology 149 (4): 1757–1772. doi:10.1210/en.2007-1205. PMC 2276704. PMID 18162525.
  - Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D (August 2013). “Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin”. Biochemistry 52 (31): 5167–5175. doi:10.1021/bi400502c. PMC 3737600. PMID 23848319.
  - Azzopardi PV, O'Young J, Lajoie G, Karttunen M, Goldberg HA, Hunter GK (February 2010). “Roles of electrostatics and conformation in protein-crystal interactions”. PLOS ONE 5 (2): e9330. Bibcode: 2010PLoSO...5.9330A. doi:10.1371/journal.pone.0009330. PMC 2824833. PMID 20174473.
  - Chien YC, Masica DL, Gray JJ, Nguyen S, Vali H, McKee MD (August 2009). “Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning”. The Journal of Biological Chemistry 284 (35): 23491–23501. doi:10.1074/jbc.M109.021899. PMC 2749123. PMID 19581305.
  - McKee MD, Hoac B, Addison WN, Barros NM, Millán JL, Chaussain C (October 2013). “Extracellular matrix mineralization in periodontal tissues: Noncollagenous matrix proteins, enzymes, and relationship to hypophosphatasia and X-linked hypophosphatemia”. Periodontology 2000 63 (1): 102–122. doi:10.1111/prd.12029. PMC 3766584. PMID 23931057.
  - Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (December 2002). “Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification”. The American Journal of Pathology 161 (6): 2035–2046. doi:10.1016/S0002-9440(10)64482-3. PMC 1850905. PMID 12466120.
  - Giachelli CM (March 1999). “Ectopic calcification: gathering hard facts about soft tissue mineralization”. The American Journal of Pathology 154 (3): 671–675. doi:10.1016/S0002-9440(10)65313-8. PMC 1866412. PMID 10079244.
  - Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, Glogauer M, Sodek J, Zohar R (December 2007). “Role of osteopontin in neutrophil function”. Immunology 122 (4): 466–475. doi:10.1111/j.1365-2567.2007.02682.x. PMC 2266047. PMID 17680800.
  - Burdo TH, Wood MR, Fox HS (June 2007). “Osteopontin prevents monocyte recirculation and apoptosis”. Journal of Leukocyte Biology 81 (6): 1504–1511. doi:10.1189/jlb.1106711. PMC 2490714. PMID 17369493.
  - Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (April 2002). “Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice”. Proceedings of the National Academy of Sciences of the United States of America 99 (7): 4556–4561. Bibcode: 2002PNAS...99.4556Y. doi:10.1073/pnas.052523599. PMC 123686. PMID 11930008.
  - Xanthou G, Alissafi T, Semitekolou M, Simoes DC, Economidou E, Gaga M, Lambrecht BN, Lloyd CM, Panoutsakopoulou V (May 2007). “Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets”. Nature Medicine 13 (5): 570–578. doi:10.1038/nm1580. PMC 3384679. PMID 17435770.
  - Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T (September 2005). “Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response”. Gut 54 (9): 1254–1262. doi:10.1136/gut.2004.048298. PMC 1774642. PMID 16099792.
  - Kourepini E, Aggelakopoulou M, Alissafi T, Paschalidis N, Simoes DC, Panoutsakopoulou V (March 2014). “Osteopontin expression by CD103- dendritic cells drives intestinal inflammation”. Proceedings of the National Academy of Sciences of the United States of America 111 (9): E856–E865. Bibcode: 2014PNAS..111E.856K. doi:10.1073/pnas.1316447111. PMC 3948306. PMID 24550510.
  - Mori R, Shaw TJ, Martin P (January 2008). “Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring”. The Journal of Experimental Medicine 205 (1): 43–51. doi:10.1084/jem.20071412. PMC 2234383. PMID 18180311.
    - “Gel 'to speed up wound healing'”. BBC News. (2008年1月22日)
    - Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, Simmons BH, Wu A, Lee JH, Bergqvist S, Kraynov E (March 2012). “Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer”. Journal of Experimental & Clinical Cancer Research 31 (1): 26. doi:10.1186/1756-9966-31-26. PMC 3325875. PMID 22444159.
    - Farrokhi V, Chabot JR, Neubert H, Yang Z (May 2018). “Assessing the Feasibility of Neutralizing Osteopontin with Various Therapeutic Antibody Modalities”. Scientific Reports 8 (1): 7781. Bibcode: 2018NatSR...8.7781F. doi:10.1038/s41598-018-26187-w. PMC 5958109. PMID 29773891.
    - Leavenworth JW, Verbinnen B, Wang Q, Shen E, Cantor H. Intracellular osteopontin regulates homeostasis and function of natural killer cells. Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):494-9. doi:10.1073/pnas.1423011112. Epub 2014 Dec 30. PMID 25550515; PMC 4299239.
    - Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest. 2012 Feb;122(2):575-85. doi:10.1172/JCI61034. Epub 2012 Jan 17. PMID 22251703; PMC 3266798.
    - Singh M, Dalal S, Singh K (November 2014). “Osteopontin: At the cross-roads of myocyte survival and myocardial function”. Life Sciences 118 (1): 1–6. doi:10.1016/j.lfs.2014.09.014. PMC 4254317. PMID 25265596.
    - Singh M, Foster CR, Dalal S, Singh K (March 2010). “Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI”. Journal of Molecular and Cellular Cardiology 48 (3): 538–543. doi:10.1016/j.yjmcc.2009.06.015. PMC 2823840. PMID 19573532.
    - Shirakawa K, Sano M (July 2021). “Osteopontin in Cardiovascular Diseases”. Biomolecules 11 (7): 1047. doi:10.3390/biom11071047. PMC 8301767. PMID 34356671.
    - Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM (November 2002). “Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle”. Proceedings of the National Academy of Sciences of the United States of America 99 (23): 15000–15005. Bibcode: 2002PNAS...9915000H. doi:10.1073/pnas.192571199. PMC 137534. PMID 12415109.
    - Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, Motoyoshi K, Kamakura K, Miyagoe-Suzuki Y, Takeda S (July 2003). “Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin”. The American Journal of Pathology 163 (1): 203–215. doi:10.1016/S0002-9440(10)63644-9. PMC 1868192. PMID 12819025.
    - Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, Miceli MC, Spencer MJ (June 2009). “Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta”. The Journal of Clinical Investigation 119 (6): 1583–1594. doi:10.1172/JCI37662. PMC 2689112. PMID 19451692.
    - Pegoraro E, Hoffman EP, Piva L, Gavassini BF, Cagnin S, Ermani M, Bello L, Soraru G, Pacchioni B, Bonifati MD, Lanfranchi G, Angelini C, Kesari A, Lee I, Gordish-Dressman H, Devaney JM, McDonald CM (January 2011). “SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy”. Neurology 76 (3): 219–226. doi:10.1212/WNL.0b013e318207afeb. PMC 3034396. PMID 21178099.

rutgers.edu

hdl.rutgers.edu

Wang KX, Denhardt DT (2008). “Osteopontin: role in immune regulation and stress responses”. Cytokine & Growth Factor Reviews 19 (5–6): 333–345. doi:10.1016/j.cytogfr.2008.08.001. PMID 18952487.

wikipedia.org

en.wikipedia.org

GRCh38: Ensembl release 89: ENSG00000118785 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000029304 - Ensembl, May 2017

worldcat.org

search.worldcat.org

“Editorial”. International Journal for Parasitology 26 (8–9): 797–798. (1996-08-09). doi:10.1016/0020-7519(96)00065-3. ISSN 0020-7519.

zenodo.org

Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW (August 1990). “cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)”. Genomics 7 (4): 491–502. doi:10.1016/0888-7543(90)90191-V. PMID 1974876. https://zenodo.org/record/1258571.